C12N 2720/12323
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2720/12323 (Virus like particles [vlp]) appears on 9 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 16
- Assignees
- 19
- Inventors
- 73
- Latest grant
- 9 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 3 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 2 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine9 Apr 2024US 11,952,400 B2Tecon Biopharmaceutical Co., Ltd.
- Rotavirus-like particle production in plants14 May 2019US 10,287,555 B2Mitsubishi Tanabe Pharma Corporation
- Rotavirus particles with chimeric surface proteins29 Jan 2019US 10,192,025 B2Novartis AG
- Method for in-vitro preparation of double-layered virus-like particles of rotavirus9 Jan 2018US 9,862,933 B2Xiamen Innovax Biotech Co., Ltd.
- Expression and assembly of human group C rotavirus-like particles and uses thereof27 Oct 2015US 9,169,296 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Rotavirus b virus-like-particle compostions and antibody assays11 Jun 2026US 2026/0158131 A1University of Kentucky Research Foundation
- Recombinant expression vector for production of encapsulin-based vaccine and method for manufacturing the same14 Mar 2024US 2024/0084310 A1Inthera Inc.
- Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof26 May 2022US 2022/0160864 A1Boehringer Ingelheim Animal Health USA Inc.
- Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine6 Jan 2022US 2022/0002350 A1Tecon Biopharmaceutical Co., Ltd.
- Rotavirus vp7 fusion proteins and rotavirus-like particles comprising them23 Dec 2021US 2021/0393765 A1Medicago Inc.
Most cited
By later US patents
- Assembled viral particles and their use in a vaccine to rotaviral disease15US 5,298,244 AUniversity of Saskatchewan · 1994
- Expression and assembly of human group C rotavirus-like particles and uses thereof3US 9,169,296 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2015
- Bovine rotavirus genes2US 5,959,093 AThe Ohio State University Research Foundation · 1999
- Norovirus capsid and rotavirus VP6 protein for use as combined vaccine2US 8,895,015 B22014
- Bovine rotavirus genes1US 6,805,867 B1The Ohio State University Research Foundation · 2004